ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LYEL Lyell Immunopharma Inc

2.77
0.06 (2.21%)
May 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Lyell Immunopharma Inc LYEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 2.21% 2.77 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.73 2.68 2.785 2.77 2.71
more quote information »

Recent News

Date Time Source Heading
5/07/202416:05GLOBELyell Immunopharma to Participate in BofA Securities Health..
5/06/202408:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/06/202408:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202408:03EDGAR2Form 8-K - Current report
5/06/202408:00GLOBELyell Immunopharma Reports Business Highlights and Financial..
3/05/202416:30GLOBELyell Immunopharma Announces the Acceptance of Three..
2/28/202416:07EDGAR2Form 8-K - Current report
2/28/202416:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
2/26/202416:05GLOBELyell Immunopharma Announces Participation in March Investor..
2/13/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202420:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
11/20/202320:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202320:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202316:26EDGAR2Form 8-K - Current report
11/09/202316:05GLOBELyell Immunopharma Receives FDA Orphan Drug Designation for..
11/07/202316:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202316:08EDGAR2Form 8-K - Current report
11/07/202316:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
10/31/202309:00GLOBELyell Immunopharma Presentations at SITC Highlight New..
9/27/202309:00GLOBELyell Immunopharma Announces the Acceptance of Six Abstracts..
9/11/202309:16EDGAR2Form 8-K - Current report
9/11/202308:00PRNUSCellares and Lyell to Evaluate Automated Manufacturing of..
8/31/202316:05GLOBELyell Immunopharma to Participate in Upcoming Investor..
8/08/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:10EDGAR2Form 8-K - Current report
8/08/202316:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
7/05/202316:05GLOBELyell Immunopharma Appoints Matthew Lang as Chief Business..
6/07/202316:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..

Your Recent History

Delayed Upgrade Clock